Global Blood Glucose Device Market to Experience Robust Growth, Predicts Renub Research in New Report Available at MarketPublishers.com
20 Jan 2017 • by Natalie Aster
LONDON – The robust growth of the incidence of diabetes is the number one factor igniting growth of the market for self-monitoring blood glucose devices. The number of people suffering from this disease is expected to hit the USD 642 million mark by 2040. The government support and funding are some other important driving forces. As a result, the market is predicted to be worth more than USD 16 billion by 2020.
The U.S. is currently the largest SMBG market globally, and it is followed by Russia and the U.K. These three countries hold a combined share of over 63% percent of the total test strips marketplace. China, however, is the leader in the blood glucose meters segment.
Roche, Abbot Laboratories and Bayer are some to major players in the SMBG universe.
New research report “Blood Glucose Device Market & Forecast (SMBG)– Worldwide Analysis” drawn up by Renub Research offers a comprehensive analysis of the worldwide SMBG market. The study commences with a thorough review of the marketplace.
It covers the user base and shares they own.
The report investigates the performance of the market segments. The research study proceeds with a discussion of major countries: the US, Italy, the Netherlands, Sweden, the U.K.
It explores forces that drive the global marketplace. Then it scrutinizes its challenges. It concentrates on the competitive landscape and examines key companies. Future predictions for the marketplace are on hand in the report, too.
- a bird’s eye view of the marketplace;
- insights into factors that drive the world’s space and challenge it;
- analysis of segments of the world’s market;
- investigation of the competitive environment;
- coverage of major countries;
- company profiles;
- detailed future outlook;
- and more.
More new reports by Renub Research can be found at its page.